These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 29980582)
61. Osteoclast-induced Foxp3+ CD8 T-cells limit bone loss in mice. Buchwald ZS; Kiesel JR; Yang C; DiPaolo R; Novack DV; Aurora R Bone; 2013 Sep; 56(1):163-73. PubMed ID: 23756229 [TBL] [Abstract][Full Text] [Related]
62. Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells. Kwan WH; van der Touw W; Paz-Artal E; Li MO; Heeger PS J Exp Med; 2013 Feb; 210(2):257-68. PubMed ID: 23382542 [TBL] [Abstract][Full Text] [Related]
63. Type I IFN signaling facilitates the development of IL-10-producing effector CD8 Jiang L; Yao S; Huang S; Wright J; Braciale TJ; Sun J Eur J Immunol; 2016 Dec; 46(12):2778-2788. PubMed ID: 27701741 [TBL] [Abstract][Full Text] [Related]
64. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Zheng Y; Josefowicz S; Chaudhry A; Peng XP; Forbush K; Rudensky AY Nature; 2010 Feb; 463(7282):808-12. PubMed ID: 20072126 [TBL] [Abstract][Full Text] [Related]
65. Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin. Bovenschen HJ; van de Kerkhof PC; van Erp PE; Woestenenk R; Joosten I; Koenen HJ J Invest Dermatol; 2011 Sep; 131(9):1853-60. PubMed ID: 21654831 [TBL] [Abstract][Full Text] [Related]
66. Role of type I interferon signaling in human metapneumovirus pathogenesis and control of viral replication. Hastings AK; Erickson JJ; Schuster JE; Boyd KL; Tollefson SJ; Johnson M; Gilchuk P; Joyce S; Williams JV J Virol; 2015 Apr; 89(8):4405-20. PubMed ID: 25653440 [TBL] [Abstract][Full Text] [Related]
67. Genetic control directed toward spontaneous IFN-alpha/IFN-beta responses and downstream IFN-gamma expression influences the pathogenesis of a murine psoriasis-like skin disease. Arakura F; Hida S; Ichikawa E; Yajima C; Nakajima S; Saida T; Taki S J Immunol; 2007 Sep; 179(5):3249-57. PubMed ID: 17709541 [TBL] [Abstract][Full Text] [Related]
68. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets. Pyzik M; Piccirillo CA J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784 [TBL] [Abstract][Full Text] [Related]
69. Regulatory B cells suppress imiquimod-induced, psoriasis-like skin inflammation. Yanaba K; Kamata M; Ishiura N; Shibata S; Asano Y; Tada Y; Sugaya M; Kadono T; Tedder TF; Sato S J Leukoc Biol; 2013 Oct; 94(4):563-73. PubMed ID: 23630391 [TBL] [Abstract][Full Text] [Related]
70. Worsening of imiquimod-induced psoriasiform inflammation in mice by environmental pollutant, di-(2-ethylhexyl) phthalate through dysregulation in IL-17A and Nrf2/iNOS signaling in peripheral myeloid and CD4 + T cells. Alfardan AS; Nadeem A; Ahmad SF; Al-Harbi NO; Alqinyah M; Attia SM; Sarawi W; Alanazi AZ; Alhazzani K; Ibrahim KE Int Immunopharmacol; 2024 Jan; 126():111293. PubMed ID: 38056199 [TBL] [Abstract][Full Text] [Related]
71. Kaempferol attenuates imiquimod-induced psoriatic skin inflammation in a mouse model. Liu C; Liu H; Lu C; Deng J; Yan Y; Chen H; Wang Y; Liang CL; Wei J; Han L; Dai Z Clin Exp Immunol; 2019 Dec; 198(3):403-415. PubMed ID: 31407330 [TBL] [Abstract][Full Text] [Related]
72. An upregulation of CD8 Zhu R; Chen L; Xiong Y; Wang N; Xie X; Hong Y; Meng Z Exp Cell Res; 2017 Sep; 358(2):182-187. PubMed ID: 28648519 [TBL] [Abstract][Full Text] [Related]
73. Role of bone marrow stromal cells in the generation of human CD8+ regulatory T cells. Poggi A; Zocchi MR Hum Immunol; 2008 Nov; 69(11):755-9. PubMed ID: 18817823 [TBL] [Abstract][Full Text] [Related]
74. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function. Bedini C; Nasorri F; Girolomoni G; Pità Od; Cavani A Br J Dermatol; 2007 Aug; 157(2):249-58. PubMed ID: 17489975 [TBL] [Abstract][Full Text] [Related]
75. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Collison LW; Workman CJ; Kuo TT; Boyd K; Wang Y; Vignali KM; Cross R; Sehy D; Blumberg RS; Vignali DA Nature; 2007 Nov; 450(7169):566-9. PubMed ID: 18033300 [TBL] [Abstract][Full Text] [Related]
77. Selective depletion of alloreactive T cells leads to long-term islet allograft survival across a major histocompatibility complex mismatch in diabetic mice. Hu M; Wu J; Zhang GY; Wang YM; Watson D; Yi S; Hawthorne WJ; O'Connell PJ; Alexander SI Cell Transplant; 2013; 22(10):1929-41. PubMed ID: 23107388 [TBL] [Abstract][Full Text] [Related]
78. Increased Tc22 and Treg/CD8 ratio contribute to aggressive growth of transplant associated squamous cell carcinoma. Zhang S; Fujita H; Mitsui H; Yanofsky VR; Fuentes-Duculan J; Pettersen JS; Suárez-Fariñas M; Gonzalez J; Wang CQ; Krueger JG; Felsen D; Carucci JA PLoS One; 2013; 8(5):e62154. PubMed ID: 23667456 [TBL] [Abstract][Full Text] [Related]
79. Intraperitoneal Echinococcus multilocularis infection in mice modulates peritoneal CD4+ and CD8+ regulatory T cell development. Mejri N; Müller N; Hemphill A; Gottstein B Parasitol Int; 2011 Jan; 60(1):45-53. PubMed ID: 20965274 [TBL] [Abstract][Full Text] [Related]
80. Anti-IL-2 treatment impairs the expansion of T(reg) cell population during acute malaria and enhances the Th1 cell response at the chronic disease. Zago CA; Bortoluci KR; Sardinha LR; Pretel FD; Castillo-Méndez SI; Freitas do Rosário AP; Hiyane MI; Muxel SM; Rodriguez-Málaga SM; Abrahamsohn IA; Álvarez JM; D'Império Lima MR PLoS One; 2012; 7(1):e29894. PubMed ID: 22272258 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]